We independently verified Omzo’s certification, clinical model, and real pricing. Here’s what holds up.
Omzo is a fully online, app-based US program built around ongoing, adjustable care. Licensed clinicians review your intake and you manage everything, weekly check-ins, dose changes, care-team messaging, through the app. A distinguishing feature is the ability to switch between medications under supervision if something is not working for you. Pricing is confirmed at checkout rather than published upfront.
Our review process checks every program against the same standard: current LegitScript certification (verified against the LegitScript directory), prescriptions issued by licensed clinicians after an individual evaluation, US-licensed pharmacy fulfillment, transparent pricing confirmed at checkout, and a support model we assess directly. Our full methodology is public.
No program is perfect, and a review that hides the cons isn’t a review. What we’d want you to know:
Best for: clinician-guided care with flexibility to adjust or switch
Yes. Omzo is a LegitScript-certified, doctor-supervised telehealth program. Prescriptions are issued only by licensed clinicians after an individual medical evaluation, and our review verified its certification, pricing, and support model. Rated 4.7/5 by GLP One Guide.
Telehealth programs themselves are not FDA-approved; medications are. Omzo offers Semaglutide & Tirzepatide. Compounded medications, where offered, are prepared by licensed pharmacies but are not FDA-approved; the FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name medications.
Omzo starts at $89/mo. Final pricing is confirmed at checkout after your medical evaluation.
Omzo connects patients with licensed US providers and LegitScript-certified pharmacies, and every prescription requires a provider review of your health history. As with any GLP-1 treatment, safety depends on proper medical screening and following your provider's dosing guidance. Compounded medications, where offered, are prepared by state-licensed pharmacies but are not FDA-approved, and they are not the same as brand-name medications.
Omzo operates as a telehealth platform working with licensed clinicians and certified pharmacies. Its LegitScript certification is a meaningful third-party trust signal, since LegitScript verifies a provider meets legal and safety standards. Independent reviews are generally positive.
Omzo uses monthly pricing that varies by medication and plan. Pricing is confirmed after your provider recommends a treatment, and multi-month plans typically lower the effective monthly cost. Always confirm current pricing at checkout.
Like most compounded-GLP-1 telehealth programs, Omzo generally operates on a cash-pay basis and does not bill insurance directly. This is common in this space and is part of why pricing is transparent and flat rather than insurance-dependent.
Third-party directory ratings can change over time, so check the most current listing directly. More important than any single score is Omzo's LegitScript certification and its use of licensed US providers and pharmacies, which are the core legitimacy signals.
We review 22 LegitScript-certified GLP-1 programs ranging from $49 to $249/mo. Our 60-second quiz matches you to the best fit for your budget and needs.
Visit Omzo → Or find your best match →
This page is for educational purposes and is not medical advice. GLP-1 medications require a prescription from a licensed clinician and are used alongside a reduced-calorie diet and exercise. Consult a doctor before starting any medication.
Price changes, new program reviews, and plain-English GLP-1 updates, straight to your inbox. Independent, and never sponsored by the programs we review.
By joining, you agree to receive emails from GLP One Guide. Unsubscribe anytime. We never sell your email. See our Privacy Policy.